Stock Events

Stock Events

Terns Pharmaceuticals (430.STU) Q2 2026 Earnings

18MayConfirmed

Q1 2026

Next

-0.25

-0.24

-0.23

-0.21

Details

Expected EPS

-0.21477010112999997

Actual EPS

N/A

Surprise EPS

0.21

Surprise Percent

+100%

Description

Terns Pharmaceuticals (430.STU) will report earnings of for Q2 2026 on May 18, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.